23rd – 26th April 2017: Metabolic Disorders and Liver Cancer, Palma de Mallorca. Organised by E. Wagner.

The overall goal of this EMBO Workshop is to provide the most important and up-to-date research in the field of liver metabolism and disease. The conference will focus on understanding the recent progress in liver diseases in order to provide a forum for discussions on mechanisms of liver cancer and metabolism. Topics presented will include the signaling pathways that regulate liver cancer and metabolism. It is also our objective to highlight the latest discoveries in liver circadian rhythm and the relevance of liver metabolism in the development of metabolic disease and liver cancer. Furthermore, advances in treating liver cancer and metabolic disorders will be discussed during the workshop.


Almost 30 million people in the European Union suffer from chronic liver diseases. Hepatocellular carcinoma is the fifth most common cause of cancer in Europe, with viral hepatitis being an important risk factor. Chronic hepatitis, alcohol consumption and obesity are the leading causes of cirrhosis. Non-alcoholic fatty liver disease (NAFLD) is becoming an epidemic with a prevalence rate around 30% due in part to the increasing incidence of obesity in Europe. Speakers will cover topics from metabolic research and diabetes to NASH, liver cancer and therapy. This range of research topics will permit participants to decipher the underlying networks regulating liver function and how they may be affected in disease.